Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Mar 14, 2024	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	444	$952.40	53,463
Nov 16, 2020	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	7,108	$561.39	53,764
Mar 14, 2024	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	182	$951.92	53,907
Mar 13, 2024	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	14,217	$971.82	54,089
Jan 27, 2020	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	1,355	$340.56	54,847
Jul 13, 2020	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	13,000	$30.63	54,951
Dec 09, 2020	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Grant, award or other acquisition pursuant to Rule 16b-3(d)	8,285	--	55,421
Dec 11, 2023	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	669	$844.09	55,963
Jan 27, 2020	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	567	$339.37	56,202
Dec 09, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	492	$753.28	56,618

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media